T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FORG
851
DELISTED
ForgeRock, Inc.
FORG
| $53.7M | 0.01% |
2,505,514
-1,377,171
| -35% | -$27.1M |
|
852
DuPont de Nemours
DD
$19.5B
| $53.6M | 0.01% |
768,810
-69,130
| -8% | -$5.66M |
|
853
Primerica
PRI
$9.62B
| $53.2M | 0.01% |
444,822
-37,292
| -8% | -$4.69M |
|
854
Realty Income
O
$59.6B
| $53M | 0.01% |
776,094
-33,474
| -4% | -$2.3M |
|
855
EPAM Systems
EPAM
$5.24B
| $52.7M | 0.01% |
178,740
-4,731
| -3% | -$1.45M |
|
856
Aptiv
APTV
$10.2B
| $52.7M | 0.01% |
591,132
-1,040,524
| -64% | -$106M |
|
|
EA
857
DELISTED
Electronic Arts
EA
| $52.5M | 0.01% |
431,842
-763,978
| -64% | -$97.4M |
|
858
Autodesk
ADSK
$54.5B
| $52M | 0.01% |
302,563
-34,659
| -10% | -$6.66M |
|
859
Eastern Bankshares
EBC
$5.37B
| $51.7M | 0.01% |
2,798,686
-33,501
| -1% | -$649K |
|
|
DHR.PRB
860
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
| $51.2M | 0.01% |
38,279
+1,016
| +3% | +$1.43M |
|
861
Power Integrations
POWI
$3.48B
| $51.2M | 0.01% |
682,517
-47,331
| -6% | -$3.84M |
|
862
Qualys
QLYS
$6.78B
| $51.1M | 0.01% |
405,428
-64,452
| -14% | -$8.44M |
|
863
Phillips 66
PSX
$92.8B
| $51.1M | 0.01% |
623,136
-49,141
| -7% | -$4.55M |
|
864
Concentrix
CNXC
$1.52B
| $51.1M | 0.01% |
376,551
+355,127
| +1,658% | +$53.4M |
|
865
Zai Lab
ZLAB
$2.92B
| $50.9M | 0.01% |
1,466,410
-53,607
| -4% | -$1.89M |
|
866
Atkore
ATKR
$3.17B
| $50.9M | 0.01% |
612,589
+7,563
| +1% | +$752K |
|
867
Monte Rosa Therapeutics
GLUE
$1.35B
| $50.8M | 0.01% |
5,249,135
-101,788
| -2% | -$1.02M |
|
|
BLD
868
DELISTED
TopBuild
BLD
| $50.4M | 0.01% |
301,347
-77,991
| -21% | -$14.3M |
|
|
HAYN
869
DELISTED
Haynes International, Inc.
HAYN
| $49.9M | 0.01% |
1,522,480
+135,155
| +10% | +$5.24M |
|
870
Boyd Gaming
BYD
$6.05B
| $49.8M | 0.01% |
1,001,967
-61,607
| -6% | -$3.56M |
|
871
Wendy's
WEN
$1.65B
| $49.8M | 0.01% |
2,638,624
+308,744
| +13% | +$5.85M |
|
872
Red Rock Resorts
RRR
$3.67B
| $49.8M | 0.01% |
1,493,068
+28,665
| +2% | +$1.15M |
|
873
Comfort Systems
FIX
$60.8B
| $49.7M | 0.01% |
597,472
+3,008
| +0.5% | +$259K |
|
874
Globus Medical
GMED
$11.5B
| $48.6M | 0.01% |
866,491
+5,224
| +0.6% | +$343K |
|
875
Dow Inc
DOW
$21.9B
| $48.6M | 0.01% |
942,195
-114,173
| -11% | -$7.31M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.